WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006084474) A STABLE PHARMACEUTICAL COMPOSITION COMPRISING A FIXED DOSE COMBINATION OF FENOFIBRATE AND AN HMG-COA REDUCTASE INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084474    International Application No.:    PCT/DK2006/050004
Publication Date: 17.08.2006 International Filing Date: 10.02.2006
IPC:
A61K 31/216 (2006.01), A61K 31/366 (2006.01), A61K 31/40 (2006.01), A61K 9/16 (2006.01), A61K 9/24 (2006.01), A61K 9/26 (2006.01)
Applicants: LIFECYCLE PHARMA A/S [DK/DK]; Kogle Alle 4, DK-2970 Hørsholm (DK) (For All Designated States Except US).
HOLM, Per [DK/DK]; (DK) (For US Only).
NORLING, Tomas [DK/DK]; (DK) (For US Only)
Inventors: HOLM, Per; (DK).
NORLING, Tomas; (DK)
Priority Data:
PA 2005 00200 10.02.2005 DK
PA 2005 00576 20.04.2005 DK
Title (EN) A STABLE PHARMACEUTICAL COMPOSITION COMPRISING A FIXED DOSE COMBINATION OF FENOFIBRATE AND AN HMG-COA REDUCTASE INHIBITOR
(FR) PREPARATION PHARMACEUTIQUE STABLE COMPRENANT UNE DOSE FIXE DE FENOFIBRATE ET D'UN INHIBITEUR DE LA HMG-COA REDUCTASE
Abstract: front page image
(EN)A pharmaceutical composition for oral administration comprising a fixed dose combination of a first solid pharmaceutical composition containing fenofibrate as the active substance and second solid pharmaceutical composition containing an HMG-CoA reductase inhibitor such as a statin as the active substance, wherein the first and the second pharmaceutical compositions are present in separate entities in a single solid dosage form. For example a multilayer tablet, a two-layer tablet, or capsules or sachets containing the active ingredients in separate granulates or beads, either granulate or bead optionally being coated with a protective coating or an entero-coating.
(FR)L'invention porte sur une préparation pharmaceutique à administration orale comprenant une première composition solide dont le principe actif est du fénofibrate et une deuxième composition solide dont le principe actif est un inhibiteur de la HMG-CoA réductase tel qu'une statine, les deux compositions étant des entités séparées réunies en une seule forme posologique, qui peut être un comprimé multicouche, un comprimé bicouche, une capsule ou un sachet contenant les principes actifs dans des granulés ou des grains séparés éventuellement enrobés d'un revêtement protecteur ou gastrorésistant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)